MDT:NYE-Medtronic plc. (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 87

Change

+0.93 (+1.08)%

Market Cap

USD 101.99B

Volume

8.97M

Analyst Target

USD 115.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in four operating segments that manufacture and sell device-based medical therapies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+1.04 (+0.79%)

USD 221.89B
SEMHF Siemens Healthineers AG

N/A

USD 67.08B
STE STERIS plc

-0.60 (-0.27%)

USD 21.55B
ZBH Zimmer Biomet Holdings Inc

+0.29 (+0.28%)

USD 20.01B
GMED Globus Medical

+0.03 (+0.04%)

USD 11.43B
SNN Smith & Nephew SNATS Inc

+0.10 (+0.39%)

USD 11.17B
PEN Penumbra Inc

-0.64 (-0.21%)

USD 10.31B
BIO Bio-Rad Laboratories Inc

+1.90 (+0.67%)

USD 10.09B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.59B
GKOS Glaukos Corp

-3.22 (-2.01%)

USD 8.45B

ETFs Containing MDT

CIB0:XETRA 9.91 % 0.00 %

N/A

N/A
CYBG:LSE VanEck Bionic Engineering.. 9.75 % 0.00 %

-0.16 (0.15%)

N/A
UMDV:SW iShares US Medical Device.. 9.28 % 0.00 %

N/A

N/A
FLV American Century ETF Trus.. 5.39 % 0.00 %

+0.22 (+0.15%)

N/A
HART IQ Healthy Hearts ETF 5.17 % 0.00 %

+0.11 (+0.15%)

USD 9.76M
DIVP The Advisors’ Inner .. 4.29 % 0.00 %

+0.15 (+0.15%)

USD 0.01B
PCIG Litman Gregory Funds Trus.. 4.19 % 0.00 %

+0.01 (+0.15%)

USD 0.03B
AGQI First Trust Exchange-Trad.. 3.62 % 0.00 %

+0.03 (+0.15%)

USD 0.06B
DXQ:CA Dynamic Active Enhanced Y.. 2.53 % 0.00 %

-0.18 (0.15%)

N/A
GDVD 2.46 % 0.00 %

N/A

N/A
DVND Touchstone ETF Trust - To.. 2.14 % 0.00 %

+0.04 (+0.15%)

USD 0.04B
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.09 % 0.00 %

-0.02 (0.15%)

N/A
XHE SPDR® S&P Health Care Eq.. 2.01 % 0.35 %

-0.64 (0.15%)

USD 0.20B
PUD.B:CA 1.85 % 0.66 %

N/A

N/A
TWAR 1.11 % 0.00 %

N/A

N/A
VCLT Vanguard Long-Term Corpor.. 0.08 % 0.07 %

+0.26 (+0.15%)

USD 13.79B
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

+0.03 (+0.15%)

USD 35.68B
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.04 %

+0.03 (+0.15%)

USD 8.61B
BLV Vanguard Long-Term Bond I.. 0.00 % 0.07 %

+0.23 (+0.15%)

N/A
DTN 0.00 % 0.38 %

N/A

N/A
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

N/A

N/A
MFDX PIMCO RAFI Dynamic Multi-.. 0.00 % 0.40 %

+0.09 (+0.15%)

USD 0.28B
JDIV J.P. Morgan Exchange-Trad.. 0.00 % 0.12 %

+0.08 (+0.15%)

N/A
VSDA VictoryShares Dividend Ac.. 0.00 % 0.35 %

+0.13 (+0.15%)

USD 0.24B
AIIQ 0.00 % 0.79 %

N/A

N/A
JIGB 0.00 % 0.14 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
INAU 0.00 % 0.00 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.14 (0.15%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.14 (0.15%)

N/A
SICK 0.00 % 0.95 %

N/A

N/A
YLD Principal Active High Yie.. 0.00 % 0.65 %

N/A

USD 0.30B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.12 (+0.15%)

CAD 0.22B
XUKS:LSE db x-trackers FTSE 100 Sh.. 0.00 % 0.00 %

+0.88 (+0.15%)

USD 7.29M
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
REVS Columbia Research Enhance.. 0.00 % 0.00 %

-0.07 (0.15%)

USD 0.06B
ABEQ Absolute Core Strategy ET.. 0.00 % 0.00 %

-0.04 (0.15%)

USD 0.09B
FLSP Franklin Liberty Systemat.. 0.00 % 0.00 %

-0.02 (0.15%)

USD 0.30B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

+0.10 (+0.15%)

USD 3.22M
AGNG Global X Aging Population.. 0.00 % 0.00 %

+0.10 (+0.15%)

USD 0.06B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.02 (+0.15%)

CAD 0.08B
QDIV Global X S&P 500® Qualit.. 0.00 % 0.00 %

+0.24 (+0.15%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.91% 71% C- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.91% 71% C- 83% B
Trailing 12 Months  
Capital Gain 1.28% 55% F 38% F
Dividend Return 3.25% 100% F 49% F
Total Return 4.53% 55% F 34% F
Trailing 5 Years  
Capital Gain -23.20% 46% F 24% F
Dividend Return 11.44% 100% F 37% F
Total Return -11.76% 54% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -2.83% 35% F 19% F
Dividend Return -0.27% 39% F 19% F
Total Return 2.57% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 19.69% 94% A 55% F
Risk Adjusted Return -1.36% 39% F 20% F
Market Capitalization 101.99B 96% N/A 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.40 75% 27%
Price/Book Ratio 2.38 54% 37%
Price / Cash Flow Ratio 17.16 52% 23%
Price/Free Cash Flow Ratio 15.86 37% 27%
Management Effectiveness  
Return on Equity 7.95% 85% 52%
Return on Invested Capital 5.31% 73% 46%
Return on Assets 4.42% 74% 70%
Debt to Equity Ratio 47.55% 50% 62%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.